VR
MRNA icon

Vision Retirement’s Moderna MRNA Stock Holding History

Vision Retirement’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Buy
500
+300
+150% +$15.5K 0.01% 277
2026
Q1 		$10.2K Hold
200
– – ﹤0.01% 412
2025
Q4 		$5.9K Buy
+200
New +$5.43K ﹤0.01% 459

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vision Retirement's MRNA Position: Q2 2026 in Review

Vision Retirement increased its Moderna (MRNA) stake by 150% in Q2 2026, buying an estimated $15.5K and bringing the position to 500 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #277.

Vision Retirement first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 730 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vision Retirement held 500 shares of Moderna worth $35K as of Q2 2026.
  • Vision Retirement bought 300 Moderna shares in Q2 2026, an estimated $15.5K.
  • Moderna made up 0.01% of Vision Retirement's portfolio in Q2 2026, its #277 holding.
  • Vision Retirement first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 730 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vision Retirement's 13F filing for Q2 2026, filed 21 Jul 2026.